Current MRSA News and Events

Current MRSA News and Events, MRSA News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 21 | 820 Results
Understanding lung infections in patients with cystic fibrosis
For young people with cystic fibrosis, lung infection with Staphylococcus aureus, MRSA, is common and is treated with antibiotics in the hope that this will prevent a decline in lung function. However there has recently been debate over the role S. aureus plays in CF lung disease. Researchers from the University of Warwick have used a new model of CF lungs which could be used to make better decisions about future use of antibiotics. (2020-11-19)

Scientists discover secret to superbug's virulence in diabetic infections
The bodies of people with uncontrolled diabetes appear to be the perfect environment for a common type of superbug to thrive unchecked and do its worst damage, according to new research reported today in Science Advances. Staphylococcus aureus -- a bacteria that is often resistant to antibiotics -- thrives in glucose-rich diabetic conditions, which trigger it to activate some of its most virulent features. A lack of insulin prevents the immune system from responding to the infection. (2020-11-13)

Hospital floors are hotspot for bacteria, creating route of transfer to patients
The floors of hospital rooms are frequently contaminated with antibiotic-resistant bacteria within hours of patient admission, creating a route of transfer of potentially dangerous organisms to patients, according to a study published today as part of the proceedings from Decennial 2020: The Sixth International Conference on Healthcare-Associated Infections. Decennial 2020, an initiative of the CDC and SHEA, was cancelled in March due to the pandemic. (2020-10-30)

Guidance balances staph infection prevention in critically ill infants with family contact
NICUs should balance prevention of Staph infections in critically ill infants with the need for skin-to-skin contact with parents and siblings, according to a Society for Healthcare Epidemiology of America white paper published in the journal Infection Control & Hospital Epidemiology. The paper serves as a clinical companion to the new recommendations from the CDC's Healthcare Infection Control Practices Advisory Committee to help clinicians in NICUs make decisions about infection prevention, detection, and control practices. (2020-09-14)

Dartmouth-led team engineers new treatment for drug-resistant bacterial infections
A new antibacterial agent that has been engineered by researchers at Dartmouth to essentially hide from the human immune system may treat life-threatening MRSA infections. A new paper, published today in Science Advances, provides details on the agent, which is the first lysin-based treatment with the potential to be used multiple times on a single patient, making it ideal to treat particularly persistent drug-resistant and drug-sensitive infections. (2020-09-02)

Vaccine that harnesses antifungal immunity protects mice from staph infection
Immunization of mice with a new vaccine consisting of fungal particles loaded with Staphylococcus aureus (S. aureus) proteins protects mice against S. aureus infection, according to a study published August 20 2020 in the open-access journal PLOS Pathogens by David Underhill of Cedars-Sinai Medical Center, and colleague. (2020-08-20)

NTU develops peptide that makes drug-resistant bacteria sensitive to antibiotics again
Scientists at NTU Singapore have developed a synthetic peptide that can make multidrug-resistant bacteria sensitive to antibiotics again when used together with traditional antibiotics, offering hope for the prospect of a combination treatment strategy to tackle certain antibiotic-tolerant infections. On its own, the synthetic antimicrobial peptide can also kill bacteria that have grown resistant to antibiotics. (2020-08-06)

High levels of antibiotic-resistant bacteria found on equipment in communal gyms
Research presented at ASM Microbe Online found that 43% of Staphylococcus bacteria found on exercise equipment in university gyms were ampicillin-resistant, with 73% of those isolates being resistant to multiple additional drugs. (2020-07-24)

Artificial intelligence can help predict the bacteria responsible for pneumonia in emergency rooms
A team of researchers showed that artificial intelligence (AI) could help predict the type of bacteria that caused the infection in patients with pneumonia. The research is presented at ASM Microbe Online, the annual meeting of the American Society for Microbiology. (2020-07-24)

Genetic mutations help MRSA to become highly resistant to antibiotics
Scientists from the University of Sheffield have found that genetic mutations in MRSA allow it to evolve and become more resistant to antibiotics such as penicillin. (2020-07-24)

Beautyberry leaf extract restores drug's power to fight 'superbug'
Laboratory experiments showed that the plant compound works in combination with oxacillin to knock down the resistance to the drug of methicillin-resistant Staphylococcus aureus, or MRSA. (2020-07-16)

Children's National Hospital quality initiative changes culture of antibiotic prescribing in NICU
A quality improvement initiative in the Neonatal Intensive Care Unit (NICU) at Children's National Hospital led to a significant reduction in treatment with intravenous vancomycin, an antibiotic used for resistant gram positive infections, which is often associated with acute kidney injury. The findings, published in the journal Pediatrics, show the initiative reduceed vancomycin use in patients by 66%, and the NICU has sustained the reduction for more than a year. (2020-07-01)

New strategy emerges for vaccine against methicillin-resistant staphylococcal aureus
Experiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments. (2020-06-30)

New killing mechanism discovered in 'game-changing' antibiotic
Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin -- a new class of potent natural antibiotic capable of killing superbugs. Research published in Nature Communications provides fundamental new insights into how teixobactins kill bacteria, including the discovery of a new killing mechanism that could help inform the design of improved teixobactin-based drugs. (2020-06-05)

A potential new weapon in the war against superbugs
Researchers in Melbourne, Australia have shown that a newly discovered natural antibiotic, teixobactin, could be effective in treating bacterial lung conditions such as tuberculosis and those commonly associated with COVID-19. (2020-06-03)

Scientists identify chemicals in noxious weed that 'disarm' deadly bacteria
Scientists have identified specific compounds from the Brazilian peppertree -- a weedy, invasive shrub in Florida -- that reduce the virulence of antibiotic-resistant staph bacteria. Scientific Reports published the research, demonstrating that triterpenoid acids in the red berries of the plant ''disarm'' dangerous staph bacteria by blocking its ability to produce toxins. (2020-05-21)

Protective shield: How pathogens withstand acidic environments in the body
Certain bacteria, including the dangerous nosocomial pathogen MRSA, can protect themselves from acidic conditions in our body and thus ensure their survival. Researchers at the Biozentrum of the University of Basel have now elucidated an important mechanism in this process. A transport protein involved in cell wall biosynthesis plays a key role, they report in the journal 'Nature Structural & Molecular Biology.' (2020-05-05)

Study suggests pets are not a major source of transmission of drug-resistant microbes to their owners
New research due to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) has identified genetically identical multidrug-resistant bacteria in humans and their pets, suggesting human-animal transfer is possible in this context. However only a small number of cases were found, suggesting this is not a major source of antibiotic-resistant infections in humans. (2020-04-19)

Now metal surfaces can be instant bacteria killers
Purdue University engineers have created a laser treatment method that could potentially turn any metal surface into a rapid bacteria killer -- just by giving the metal's surface a different texture. (2020-04-09)

New study: Cannabis helps fight resistant bacteria
Bacteria are increasingly becoming resistant to antibiotics. By combining antibiotics with the cannabis compound, cannabidiol, researchers have found a way to enhance the antibiotic effect. (2020-03-24)

Newfound cell defense system features toxin-isolating 'sponges'
A 'decoy' mechanism has been found in human and animal cells to protect them from potentially dangerous toxins released by foreign invaders, such as bacteria. (2020-03-04)

SFU team helps discover potential superbug-killing compound
Researchers in Simon Fraser University's Brinkman Laboratory are collaborating with US researchers to test a new drug that can kill a wide range of superbugs -- including some bacteria now resistant to all common antibiotics. (2020-03-03)

Scientists discover new 'Jekyll and Hyde' immune cell
Scientists at Trinity College Dublin have identified a rare, new cell in the immune system with 'Jekyll and Hyde properties.' These cells play a key protective role in immunity to infection but -- if unregulated -- also mediate tissue damage in autoimmune disorders. The findings should help us design more effective vaccines to prevent infections such as MRSA, and may also assist help us develop of new therapies for autoimmune diseases, such as multiple sclerosis or rheumatoid arthritis. (2020-02-27)

Cannabis compound acts as an antibiotic 
Public health agencies worldwide have identified antibiotic resistance of disease-causing bacteria as one of humanity's most critical challenges. However, scientists haven't discovered a new class of antibiotics in more than 30 years. Now, researchers reporting in ACS Infectious Diseases have uncovered the hidden antibiotic potential of a non-psychoactive cannabis compound called cannabigerol (CBG), which helped control methicillin-resistant Staphylococcus aureus (MRSA) infections in mice. (2020-02-26)

McMaster researchers uncover hidden antibiotic potential of cannabis
The research team found that CBG had antibacterial activity against drug-resistant MRSA. It prevented the ability of that bacteria to form biofilms, which are communities of microorganisms that attach to each other and to surfaces; and it destroyed preformed biofilms and cells resistant to antibiotics. CBG achieved this by targeting the cell membrane of the bacteria. These findings in the laboratory were supported when mice with an MRSA infection were given CBG. (2020-02-26)

No benefit found in using broad-spectrum antibiotics as initial pneumonia treatment
Doctors who use drugs that target antibiotic-resistant bacteria as a first-line defense against pneumonia should probably reconsider this approach, according to a new study of more than 88,000 veterans hospitalized with the disease. The study, conducted by University of Utah Health and VA Salt Lake City Health Care System researchers, found that pneumonia patients given these medications in the first days after hospitalization fared no better than those receiving standard medical care for the condition. (2020-02-26)

Metals could be the link to new antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance. University of Queensland researchers, working with a network of international collaborators, have discovered 23 previously unexplored compounds containing metals such as silver, manganese, zinc, ruthenium and iridium that have antibacterial and antifungal activity. (2020-02-26)

Second antibiotic no advantage for treating super-bug Golden Staph
A world-first clinical trial has called into question the effectiveness of using more than one antibiotic to treat the deadly 'super-bug', Methicillin-resistant staphylococcus aureus (MRSA) Bacteremia, commonly known as Golden Staph. (2020-02-13)

Trial shows using two drugs not better than one when treating MRSA blood infections
Researchers attempting to improve the treatment for methicillin-resistant Staphylococcus aureus (MRSA) blood infections have discovered the combination of two antibiotics was no better than one, and led to more adverse effects. In what is the biggest trial of MRSA bloodstream infections to date, (352 participants from Australia, Singapore, New Zealand and Israel), the CAMERA2 clinical trial, researchers were surprised to see the drug combination wasn't as effective as anticipated. (2020-02-11)

Sticky antibiotic provides glue for successful treatment
Researchers have found how an antibiotic used to treat a debilitating gut infection stays put inside the body giving it time to effectively treat the problem, a discovery that will pave the way for the development of more effective antibiotic treatments to fight superbugs. (2020-01-22)

Israeli docs strike big blow to superbugs
In a study published in Science magazine, the researchers showed that aggressive bacteria can be controlled -- but only if doctors administer treatment within a short window of opportunity. (2020-01-13)

Antibiotic tolerance reduces the ability to prevent resistance under drug combination therapies
Antimicrobial tolerance can promote the evolution of antimicrobial resistance even under combination drug treatments widely used and expected to prevent it from occurring, a new study finds. (2020-01-09)

Trial suggests babies in intensive care can be better protected from parental bacteria
Now, a Johns Hopkins Medicine research team reports it has developed and tested a relatively simple strategy for reducing the chance of parents exposing their babies in the NICU to one of the most commonly diagnosed and potentially deadly microbial scourges in a hospital: Staphylococcus aureus. The researchers detailed the positive findings from their preliminary clinical trial in the Dec. 30, 2019, issue of the Journal of the American Medical Association (JAMA). (2019-12-31)

From cancer medication to antibiotic
Antibiotic-resistant bacteria are increasingly the source of deadly infections. A team of scientists from the Technical University of Munich (TUM) and the Helmholtz Center for Infection Research (HZI) in Braunschweig have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens. (2019-12-16)

A self-cleaning surface that repels even the deadliest superbugs
A team of researchers at McMaster University has developed a self-cleaning surface that can repel all forms of bacteria, preventing the transfer of antibiotic-resistant superbugs and other dangerous bacteria in settings ranging from hospitals to kitchens. (2019-12-13)

SMART and NTU researchers design polymer that can kill drug-resistant bacteria
Researchers from Singapore-MIT Alliance for Research and Technology (SMART) and Nanyang Technological University (NTU) have developed an antimicrobial polymer that can kill bacteria resistant to commonly used antibiotics - a discovery that can pave the way for developing antibiotics to which bacteria are significantly less resistant. The new beta-peptide polymer can combat superbugs like Methicillin-resistant Staphylococcus aureus (MRSA), and it also works against biofilm and persistent bacteria for which current antibiotics have proved ineffective. (2019-12-12)

Crossing borders and growing resistance: a superbug from south Asia
Using whole genome sequencing, researchers have been able to trace the origins and global spread of a multi-drug resistant, community Staphylococcus aureus lineage from the Indian subcontinent, known as the Bengal Bay clone. (2019-11-26)

Potent antimicrobial found that shows promise in fighting staph infections
After screening thousands of small molecules, the research team discovered a potent new antimicrobial they are calling MAC-545496 that is active against MRSA. Unlike conventional antibiotics, this new antimicrobial neither kills the staph infection nor halts its growth on its own, so the potential for antimicrobial resistance may be considerably lessened. (2019-11-25)

Antibiotics: New substances break bacterial resistance
Researchers at the Martin Luther University Halle-Wittenberg (MLU) have developed a new, promising class of active ingredients against resistant bacteria. In initial tests in cell cultures and insects, the substances were at least as effective as common antibiotics. The new compounds target a special enzyme that only appears in bacteria in this specific form and that was not previously the target of other antibiotics. The team reported on its work in the journal ''Antibiotics''. (2019-11-11)

Scientists discover how potent bacterial toxin kills MRSA bacteria
Scientists from the University of Sheffield have discovered how a potent bacterial toxin is able to target and kill MRSA, paving the way for potential new treatments for superbugs. (2019-11-04)

Page 1 of 21 | 820 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.